TREATMENT OF ARTERIAL HYPERTENSION IN PREGNANT WOMEN

##article.authors##

  • Kamolova Diyora Djamshedovna ##default.groups.name.author##

##semicolon##

Key words: hypotensive therapy, pregnancy, central hemodynamics.

##article.abstract##

ABSTRACT 
The  purpose  of this study was a  comparative  assessment  of the effect  of the 
selective  beta-1  adrenoblocker  metoprolol,  clonidine  and  methyldopa  on  the 
hemodynamic parameters of the mother and the condition of the fetoplacental complex. 
60 pregnant women with grade II hypertension and 20 healthy women were examined, 
compared  they differ in age and gestation period. The patients were divided into 3 
clinically equivalent groups, the first of which received metoprolol 50 mg 2 times a 
day  as  a  hypotensive  agent  (with  stabilization  of  the  figures  Blood  pressure  was 
switched to a maintenance dose of 25 mg / day), the second – clonidine at a dose of 
0.075  mg  2-3  times  a  day,  the  third  –  methyldopa  250  mg  2  times  a  day.  The 
effectiveness of treatment was assessed according to the data of echocardiography of 
the mother, additional plerometry of the fetal placental vessels, fetal cardiotocography, 
and  the  results  of  histological  examination  of  the  placentas.  In  the  treatment  of 
hypertension in pregnant women with hyperkinetic type of central hemodynamics , 
metoprolol  was  more  effective  than  clonidine  and  methyldopa  in  reducing  blood 
pressure, normalizing  increased the indicators  of the  central  hemodynamics  of the 
mother, restored blood flow in the fetoplacental system, increased the reactivity of the 
fetal cardiovascular system. Clinical effects of clonidine have been noted in patients 
current with hypokinetic type of central hemodynamics, methyldopa – with eukinetic 
type of blood circulation preferences. 
Antihypertensive  therapy  in  pregnant  women  with  hypertension  should  be 
differentiated  and  dependent  the  network  depends  on  the  type  of  central 
hemodynamics. 

##submission.citations##

LITERATURE

1. Ziyadullaev, S. K., Sultonov, I. I., Dushanova, G. A., & Akbarovna, K. S.

(2021). The Effectiveness Of Pharmacotherapy For Dmards With Ra Depending

On The C3435t Polymorphism Of The Mdr1 Gene. Int. J. of Aquatic

Science, 12(3), 2908-2916.

2. Islomovich, S. I. (2024). GENDER CHARACTERISTICS OF THE CURRENT

RHEUMATOID ARTHRITIS. International journal of medical sciences, 4(10),

3-8.

3. Хамраева, Н. А., Султонов, И. И., & Хасанов, Ф. Ш. У. (2019). Кожные

проявления у больных системной красной волчанкой. Вопросы науки и

образования, (28 (77)), 128-131.

4. Sultonov, I. I., Kh, Z. S., Ruzybakieva, M. R., Kireev, V. V., Aripova, T. U., &

Suyarov, A. A. (2021). Pharmacogenetic Aspects of Drug Resistance in

Rheumatoid Arthritis. Annals of the Romanian Society for Cell Biology, 4147-

4150.

5. Kireev, V. V., & Sultonov, I. I. (2021). Genetic Engineered Preparations-An

Innovative Approach in the Treatment of Rheumatoid Arthritis. Annals of the

Romanian Society for Cell Biology, 4114-4119.

6. Hamraeva, N. A., Sultonov, I. I., & Hasanov, F. S. (2020). Systemic lupus

erythematosus treatment strategy. Journal of Critical Reviews, 7(9), 269-270.

7. Тоиров, А. Э., Султонов, И. И., & Тоиров, Э. С. (2020). ЗНАЧЕНИЕ

ДИСФУНКЦИИ ПОЧЕК У БОЛЬНЫХ ОСТРЫМ ИНФАРКТОМ

МИОКАРДА НА ФОНЕ САХАРНОГО ДИАБЕТА 2-ГО ТИПА. Вестник

науки и образования, (9-3 (87)), 86-91.

8. Иргашева, У. З., Султонов, И. И., & Тоиров, Д. Р. (2013). Признаки дебюта

системной красной волчанки. Академический журнал Западной

Сибири, 9(1), 15-15.

9. Xasanov, F. S., & Sultonov, I. I. (2023). RHEUMATOID ARTHRITIS

TREATED WITH DMARDS AND CARDIOVASCULAR DISEASE

RISK. Oriental Journal of Medicine and Pharmacology, 3(02), 45-52.

10. Нурматова, Л., Султонов, И., & Тоиров, Э. (2011). Эффективность

препаратов пищеварительной активности в комплексном лечении больных

хроническим гепатитом. Журнал проблемы биологии и медицины, (3 (66)),

107-110.

11. Sultonov, I. I., Khamrayev, X. X., & Xasanov, F. SYSTEMIC LUPUS

ERYTHEMATOSUS AND CARDIOVASCULAR PATHOLOGY: WHERE

WE AT?.

12. Sultonov, I. I., Xasanov, F. S., Eshmuratov, S., Uralov, R. S., Shukurova, D., &

Ziyadullayev, S. X. Predictors of Systemic Lupus Erythematosus: A Case-

control Study. International journal of health sciences, 6(S10), 175-182.

13. Khusainova, M. A., Toirov, D. R., Khaydarov, S. N., & Kamolova, D. D. (2023).

MORPHOFUNCTIONAL PARAMETERS OF THE HEART IN WOMEN

SUFFERING FROM ESSENTIAL ARTERIAL HYPERTENSION IN

POSTMENOPAUSE AND ON THE BACKGROUND OF

TREATMENT. Oriental renaissance: Innovative, educational, natural and

social sciences, 3(1), 322-330.

14. Djamshedovna, K. D., Alisherovna, K. M., Xudoyberdiyevich, G. X., &

Rustamovich, T. D. (2023). EFFECTIVENESS OF ANTIHYPERTENSIVE

THERAPY IN PREGNANT WOMEN. Spectrum Journal of Innovation,

Reforms and Development, 12, 137-144.

15. Alisherovna, K. M., Erkinovna, K. Z., Djamshedovna, K. D., &

Nizamitdinovich, K. S. (2023). QUALITY OF LIFE PATIENTS WITH

OSTEOARTHRITIS. Journal of new century innovations, 36(1), 164-175.

16. Djamshedovna, K. D., & Alisherovna, K. M. (2024). CHANGES IN SOME

SYSTEM INDICATORS IN PREGNANT WOMEN WITH

GESTOSIS. Spectrum Journal of Innovation, Reforms and Development, 25,

111-115.

17. Alisherovna, K. M., Erkinovna, K. Z., Djamshedovna, K. D., &

Nizamitdinovich, K. S. (2023). QUALITY OF LIFE PATIENTS WITH

OSTEOARTHRITIS. Journal of new century innovations, 36(1), 164-175.

18. Jamshedovna, K. D., Alisherovna, K. M., Erkinovna, K. Z., & Davranovna, M.

K. (2022). LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN

PREGNANT WOMEN WITH PRE-ECLAMPSIA WITHOUT

PROTEINURIA. Spectrum Journal of Innovation, Reforms and

Development, 10, 135-140.

19. Rustamovich, T. D., Alisherovna, K. M., Djamshedovna, K. D., &

Nizamitdinovich, K. S. (2023). Features of the psychoemotional status of

patients with rheumatoid arthritis. Miasto Przyszłości, 32, 23-30.

20. Alisherovna, K. M., Djamshedovna, K. D., Totlibayevich, Y. S., &

Boymamatovna, E. F. (2022). The Effectiveness of the Original Drug

Trimetazidine MV in Patients with Stable Ischemic Heart Disease and Persistent

Angina Attacks Against the Background of the Use of Trimetazidine

Generics. Miasto Przyszłości, 30, 235-238.

21. Alisherovna, K. M., & Djamshedovna, K. D. (2024). AFTER COVID-19

QUALITY OF LIFE. Spectrum Journal of Innovation, Reforms and

Development, 25, 103-110.

22. Alisherovna, K. M., Jamshedovna, K. D., Totlibayevich, Y. S., &

Xudoyberdiyevich, G. X. (2022). FEATURES OF THE QUALITY OF LIFE

OF PATIENTS WITH CHRONIC RENAL FAILURE IN THE TREATMENT

OF HEMODIALYSIS. Spectrum Journal of Innovation, Reforms and

Development, 7, 76-81.

23. Xudoyberdiyevich, G. X., Alisherovna, K. M., Rustamovich, T. D., &

Djamshedovna, K. D. (2023). QUALITY OF LIFE IN PATIENTS WITH

GOUT. Spectrum Journal of Innovation, Reforms and Development, 12, 156-

164.

24. Davranovna, M. K. D. K., Alisherovna, K. M., & Erkinovna, K. Z. (2024).

CARDIAC ARRHYTHMIAS IN PATIENTS WITH RHEUMATOID

ARTHRITIS. Spectrum Journal of Innovation, Reforms and Development, 26,

65-71.

25. Alisherovna, K. M., Ismatullayevich, M. A., & Nuriddinovna, E. N. (2024).

FEATURES OF HEART FAILURE IN PATIENTS WITH CORONARY

HEART DISEASE AND THYROTOXICOSIS. Ta'lim innovatsiyasi va

integratsiyasi, 19(4), 52-61.

26. Alisherovna, K. M., Yaxshiboyevich, U. M. R., & Yigitaliyevich, B. A. (2024).

EVALUATION OF A NATRIURETIC PEPTIDE TO OPTIMIZE THE

MANAGEMENT OF COMORBID PATIENTS WITH THYROTOXICOSIS

AND HEART FAILURE. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 62-70.

27. Alisherovna, K. M., Erkinovna, S. D., Yazdonkulovna, X. M., & Zafarovna, C.

M. M. (2024). ATRIAL FIBRILLATION IN THYROTOXICOSIS–

DETERMINANTS OF DEVELOPMENT AND CONSERVATION. Ta'lim

innovatsiyasi va integratsiyasi, 19(4), 103-113. 28. Alisherovna, K. M., Mansurovna, M. D., Erkinovna, N. D., Farxodovna, X. R.,

Toxirovna, M. M., Tolibovna, R. D., & Yorkinovna, E. N. (2024). ARTERIAL

HYPERTENSION AND THYROID STATUS IN PATIENTS OF DIFFERENT

AGES. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 122-129.

29. Alisherovna, K. M., Erkinovna, S. D., Duskobilovich, B. S., & Samandarovich,

T. H. (2024). ARTERIAL HYPERTENSION IN THYROTOXICOSIS AND

REMODELING OF THE LEFT VENTRICLE OF THE HEART. Ta'lim

innovatsiyasi va integratsiyasi, 19(4), 114-121.

30. Alisherovna, K. M., Habibulloyevna, I. M., & Voxidovna, R. F. (2024).

STRUCTURAL AND FUNCTIONAL FEATURES OF THE LEFT

VENTRICLE IN PATIENTS WITH HEART FAILUREIN ISCHEMIC

HEART DISEASE AND THYROTOXICOSIS. Ta'lim innovatsiyasi va

integratsiyasi, 19(4), 71-81.

##submission.downloads##

##submissions.published##

2024-10-22